MC2-25
N/A
Report date: 2022/11/27 19:39:09
Base Information
Drug NameMC2-25
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[6]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMc2 Therapeutics Ltd
China Registration ClassN/A
Develop Information
Active CompaniesUniversity Medical Center GroningenMc2 Therapeutics Ltd
Inactive CompaniesN/A
Active Indications +[6]
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A